SUMMARY: The St. Louis Symphony Orchestra (SLSO) announced that single tickets for its 2025-2026 season are now on sale, featuring two new shows: “Dolly Parton’s Threads: My Songs in Symphony” on Jan. 17-18, combining multimedia storytelling and symphonic renditions of Dolly’s hits, and “Tower of Power,” an R&B funk band collaboration with SLSO on April 15. The season unfolds at the recently renovated $140 million Powell Hall, reopening in September. The 145th season’s lineup includes classics, film concerts, and special events, with tickets available via the SLSO website or box office.

Read the full article

The post SLSO announces single tickets sale, adds additional shows to 25-26 season appeared first on fox2now.com

SUMMARY: Summer parties are all about good food, great company, and refreshing drinks. Marcel Salazar, entertaining expert, suggests stress-free hosting with ready snacks and beverages. For large gatherings, signature punches like the sustainably sourced Great Welsh, with vibrant botanicals, are ideal. For beach or pool days, Josh Cellars offers crisp wines like Pinot Grigio and a non-alcoholic sparkling prosecco perfect for mocktails. For al fresco meals, The Crossings Sauvignon Blanc pairs well with grilled chicken, shrimp, and fish. All featured drinks focus on sustainability and flavor, enhancing any summer occasion. More info at ReserveOur.com.

SPONSORED – Chef Marisel Salazar shares with us some unique ways to enhance summer gatherings with creative recipes and …

Source

by Jacob Richey, Missouri Independent
July 24, 2025

Missouri Attorney General Andrew Bailey is suing the national Planned Parenthood organization over its claims regarding the abortion drug mifepristone.

Bailey filed the lawsuit against the Planned Parenthood Federation of America on Wednesday in Cole County Circuit Court.

The lawsuit argues Planned Parenthood’s national organization has misled consumers about the safety of mifepristone, which is used in a regimen with another drug to expel a pregnancy.

The lawsuit seeks more than $1.8 million in civil penalties, up to $1,000 in damages or restitution for every Missouri woman Planned Parenthood provided abortion pills to in the past five years, reimbursement to the state for Medicaid and other taxpayer-funded emergency care resulting from abortion pill complications, and a court order for Planned Parenthood to stop certain advertisements for mifepristone.

Mifepristone is a drug used for medication abortions. Planned Parenthood says the drug is safe and effective, but Bailey points to a small percentage of patients who need emergency care after having a medication abortion.

The U.S. Food and Drug Administration information and label for the medication says it can cause serious and sometimes fatal infections or bleeding, but that label also says U.S. clinical studies found serious adverse effects in less than 0.5% of patients.

Bailey’s lawsuit points to that label, along with other studies that say 4.6% of women who undergo a medication abortion may need emergency care after the procedure.

The lawsuit takes aim at Planned Parenthood’s comparison between mifepristone and other common medications like Tylenol, penicillin and Viagra. An archived page from Planned Parenthood’s website, which is linked in the lawsuit, said medication abortions are safer than those over-the-counter drugs.

The lawsuit says that claim is misleading, if not false, for reasons including the abortion pill and the other drugs having different uses.

While Bailey’s lawsuit doesn’t directly target Missouri’s Planned Parenthood affiliates, the lawsuit says Planned Parenthood’s advertisements for the abortion pill directs consumers to Missouri’s Planned Parenthood locations.

Medication abortions are not currently available at Missouri Planned Parenthood locations. Planned Parenthood Great Plains President and CEO Emily Wales said in a March statement that the abortion pill hasn’t been available in Missouri since 2018. Bailey’s lawsuit concerns medication abortions women from Missouri have undergone since 2020.

Since the lawsuit does not target abortions performed in Missouri, but abortions Missouri women have received, it applies to out-of-state medication abortions.

In the roughly two and a half years between the overturning of Roe v. Wade and abortions becoming available in Missouri again, Missouri residents had to go to other states like Kansas or Illinois, where abortion was legal, to obtain medication abortions.

“Planned Parenthood’s false advertising has a national reach,” Bailey said in a press release, “including targeted claims against Missouri women.”

This story originally appeared in the Columbia Missourian. It can be republished in print or online. 

Missouri Independent is part of States Newsroom, a nonprofit news network supported by grants and a coalition of donors as a 501c(3) public charity. Missouri Independent maintains editorial independence. Contact Editor Jason Hancock for questions: info@missouriindependent.com.

The post Missouri AG sues Planned Parenthood, claims it misled patients over safety of abortion pill appeared first on missouriindependent.com

Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Center-Right

This article reports on Missouri Attorney General Andrew Bailey’s lawsuit against Planned Parenthood concerning abortion pill safety claims. The framing centers on Bailey’s legal actions and critiques of Planned Parenthood’s messaging, reflecting a perspective aligned with conservative, pro-legal-challenge viewpoints on abortion-related issues. The language is factual but emphasizes the risks and legal repercussions associated with abortion medication, consistent with a center-right position that often scrutinizes abortion providers. However, the article maintains a mostly neutral tone by including statements from Planned Parenthood and citing FDA data, avoiding overt editorializing.